Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.120
+0.030 (1.44%)
At close: Nov 12, 2026, 4:00 PM EST
2.115
-0.005 (-0.24%)
After-hours: Nov 12, 2026, 4:10 PM EST
Compugen Revenue
Compugen had revenue of $3.82M in the quarter ending September 30, 2026, with 102.06% growth. This brings the company's total for the last twelve months to $75.93M, up 999.97% year-over-year. In the year 2025, Compugen had annual revenue of $72.76M with 161.14% growth. That makes Compugen the 24,838th largest company in the world by revenue and 3,474th in the United States.
Revenue (ttm)
$75.93M
Revenue Growth
+999.97%
P/S Ratio
2.64
Revenue / Employee
$1,012,413
Employees
75
Market Cap
200.82M
Revenue by Geography
- United Kingdom 65.00M 89.3%
- United States 7.76M 10.7%
Fiscal year ended Dec 31, 2025 See the full Compugen breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.76M | 44.90M | 161.14% |
| Dec 31, 2024 | 27.86M | -5.60M | -16.72% |
| Dec 31, 2023 | 33.46M | 25.96M | 346.12% |
| Dec 31, 2022 | 7.50M | 1.50M | 25.00% |
| Dec 31, 2021 | 6.00M | 4.00M | 200.00% |
| Dec 31, 2020 | 2.00M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 17.80M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 712.00K | -8.57M | -92.33% |
| Dec 31, 2015 | 9.28M | -3.09M | -24.99% |
| Dec 31, 2014 | 12.37M | 8.82M | 248.46% |
| Dec 31, 2013 | 3.55M | 3.31M | 1,366.53% |
| Dec 31, 2012 | 242.00K | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 1.12M | 865.00K | 346.00% |
| Dec 31, 2009 | 250.00K | -88.00K | -26.04% |
| Dec 31, 2008 | 338.00K | 158.00K | 87.78% |
| Dec 31, 2007 | 180.00K | -35.00K | -16.28% |
| Dec 31, 2006 | 215.00K | -431.00K | -66.72% |
| Dec 31, 2005 | 646.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Keros Therapeutics | 40.76M |
| Alpha Cognition | 15.26M |
| MediWound | 11.86M |
| Pyxis Oncology | 11.04M |
| Whitehawk Therapeutics | 7.15M |
| Fate Therapeutics | 4.75M |
| Entrada Therapeutics | 3.98M |
| Sol-Gel Technologies | 1.80M |
CGEN News
- 2 days ago - Compugen Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 2 days ago - Compugen to Present UnigenX™ Platform at the 18th Annual PEGS Europe Summit - PRNewsWire
- 3 days ago - Compugen Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Compugen Earnings release: Q3 2026 - Filings
- 3 days ago - Compugen reports Q3 EPS (6c), consensus (9c) - TheFly
- 3 days ago - Compugen Reports Third Quarter 2026 Results - PRNewsWire
- 5 days ago - Compugen Slides: Corporate presentation - Filings
- 9 days ago - Compugen to Participate in November Investor Conferences - PRNewsWire